CANCER IMMUNOTHERAPY EVALUATION METHOD, CANCER IMMUNOTHERAPY EVALUATION DEVICE, CANCER IMMUNOTHERAPY EVALUATION PROGRAM, CANCER IMMUNOTHERAPY EVALUATION SYSTEM, AND INFORMATION COMMUNICATION TERMINAL DEVICE

摘要

The purpose of the present invention is to provide a cancer immunotherapy evaluation method, a cancer immunotherapy evaluation device, a cancer immunotherapy evaluation method, a cancer immunotherapy evaluation program, a cancer immunotherapy evaluation system and an information communication terminal device, each of which can evaluate the therapeutic effect of a cancer immunotherapy with high accuracy utilizing a blood amino acid concentration. In the present embodiment, both pre-therapy amino acid concentration data, which relates to a value of the concentration of an amino acid in blood collected from a subject of interest who is intended to treated by a cancer immunotherapy prior to the start of the therapy, and post-therapy amino acid concentration data, which relates to a value of the concentration of the amino acid in blood collected from the subject of interest after the start of the therapy, are obtained, and the effect of the therapy on the subject is evaluated on the basis of the pre-therapy amino acid concentration data and the post-therapy amino acid concentration data obtained.